YB-101Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease

Sponsor:

Yarrow Bioscience, Inc.

Code:

NCT07682896

Conditions

Graves' Disease

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Experimental: YB-101

Placebo YB-101

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-22. This information was provided to ClinicalTrials.gov by Yarrow Bioscience, Inc. on 2026-07-28.